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 Osteoporosis is a skeletal disease that currently affects 10 million Americans, and is 
characterized by low bone mass and increased skeletal fragility (National Osteoporosis 
Foundation, 2011). Estrogen loss, which begins during menopause, is the leading cause of 
osteoporosis in women. Recent research has focused on changes in cortical bone microporosity 
due to estrogen loss, which is important for bone health; load-induced interstitial fluid flow 
within the lacunar-canalicular porosity surrounding osteocytes is thought to play an important 
role in bone maintenance, while the vascular porosity provides a pressure relaxation mechanism 
for the fluid flow in the lacunar-canalicular porosity. Recent high-resolution micro-CT studies 
show that the cortical vascular porosity and average vascular canal diameter increase in the tibia 
metaphysis of ovariectomized (OVX) rats (Larriera et al., 2010). The present study investigated 
whether osteoclast resorption is responsible for the increased canal diameter, and if changes in 
the cortical blood vessel morphology occur due to estrogen loss. Alterations in the vascular 
porosity and bone vasculature were assessed using the rat OVX model at one and two weeks 
post-OVX, and analyzed histologically using TRAP enzyme and Goldner’s Trichrome staining. 
No differences in TRAP activity or vasculature morphology between OVX and sham-operated 
animals were found for all measurements one and two weeks post-surgery, signifying that 
osteoclast resorption may not be the primary mechanism for the increased canal diameter 
demonstrated previously. These results also suggest that cortical blood vessel morphology is 
unchanged at these time points. All parameters quantified in this thesis will be analyzed six 
weeks post-OVX to see if there are changes at the time point corresponding to the previous 
micro-CT analyses. While additional research is needed, this study begins to unveil the ways in 
which postmenopausal osteoporosis affects the microporosity in cortical bone.   
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B. BACKGROUND AND SIGNIFICANCE 
B.1 Introduction 
 Osteoporosis is the leading bone disease in the United States (National Osteoporosis 
Foundation, 2011), and osteoporosis due to estrogen loss severely affects postmenopausal 
women. To date, the ways in which variations in the vascular porosity and blood supply 
contribute to changes in bone health and communication between cells have not been clearly 
explained. This study aims to identify changes occurring in the vascular porosity due to 
postmenopausal osteoporosis as assessed through the ovariectomized rat model and histological 
techniques.  
B.2 Bone Overview 
The skeletal system is composed of connective tissue including bone, cartilage, 
ligaments, and tendons. Bone is responsible for protection of the internal organs, structural 
support, movement, haematopoiesis (blood cell formation through bone marrow), calcium 
storage, and endocrine regulation (Jee, 2001). Tendons and ligaments connect bone to muscle 
and bone to bone, respectively, linking the body’s structural support and the mechanical force of 
movement.  
Bone is 65% inorganic (or mineral) material and 35% organic material including cells, 
proteins, and water (Downey and Siegel, 2006; Robey and Boskey, 2008). The organic matrix of 
bone is composed of 95% type I collagen and 5% non-collagenous proteins (Marks and Odgren, 
2002), which are responsible for organizing the cellular matrix, mineral-matrix interactions, and 
mineralization (Robey and Boskey, 2008). The organic matrix is deposited by bone forming 
cells, and is then infiltrated by the mineral component of bone, hydroxyapatite 
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(Ca10(PO4)6(OH)2). Hydroxyapatite strengthens bone, and provides a source of ions and minerals 
(Robey and Boskey, 2008).  
Cortical (or compact) and cancellous (or 
trabecular) are the two types of bone in the adult 
skeleton with relative amounts of 80% and 20%, 
respectively (Downey and Siegel, 2006). Cortical bone 
is the thin outer shell, while cancellous bone is the 
inner portion of bone found in the proximal and distal 
sites of long bones (Figure 1). While cortical bone 
accounts for more mass than cancellous bone, it covers 
less total bone surface, and, in humans, is largely 
composed of primary and secondary osteons. Osteons 
(250-300 µm in diameter) (Robling et al., 2006) are vascular canals surrounded by concentric 
circles of lamellar bone, and secondary osteons are a product of bone remodeling (Figure 2). 
Osteons make up the inter-network of cortical bone, and are connected by the lacunar-canalicular 
porosity (Section B.5).  
B.3 Bone Cells 
 Osteocytes, osteoclasts, osteoblasts, and bone-lining cells are the four types of bone cells 
responsible for bone formation, resorption, maintenance, and health. Osteoblasts are bone-
forming cells derived from mesenchymal cells, and are approximately 15 to 30 µm in diameter 
(Jee, 2001). They are cuboidal in shape, and secrete type I collagen and bone matrix proteins in 
order to form the organic matrix.  
Figure 1.  Cortical and cancellous bone. Adapted 
from [Downey and Siegel, 2006]. 
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Osteocytes are derived from osteoblasts that become embedded in the mineralized matrix, 
and are responsible for mechanotransduction and bone health. These cells sit in lacunae (10 to 20 
µm) (Ardizzoni, 2001; Bonewald, 2008) and have long processes located in canaliculi (100-300 
nm diameter) (You et al., 2004; Bonewald, 2006) that branch off the osteocyte lacuna and travel 
through the bone matrix (Klein-Nulend et al., 2003) (Figure 2). The canaliculi contain the 
osteocyte’s dendritic protrusions that also extend throughout the matrix, and are surrounded by a 
pericellular space and fluid (~80 nm wide on each side) (You et al., 2004). The osteocytes’ 
dendrites connect with other cells via gap junctions (Doty, 1981), and with the periosteum, blood 
vessels, and bone marrow (Klein-Nulend et al., 2003; Bonewald, 2006). Interstitial fluid flows 
around the osteocyte process, 
through the canaliculi, and initiates 
osteocyte signaling in bone (Wang 
et al., 2007). 
Osteoclasts are large cells 
(20 to 100 µm) with many nuclei 
(Jee, 2001). These cells are 
responsible for the remodeling of 
bone and bone resorption. The 
enzyme Tartrate-Resistant Acid 
Phosphatase (TRAP) is an enzyme 
released to by the osteoclast during bone resorption, and is a well-known marker for osteoclast 
activity and differentiation (Anderson and Marks, 1989).  
      
     Figure 2. Part of an osteon with osteocytes and canaliculi embedded in 
     lamellar bone. Adapted from [Cowin, 1999]. 
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Bone-lining cells, approximately 1 µm thick and up to 12 µm long (Jee, 2001), are 
inactive osteoblasts that flatten out and line the quiescent bone surfaces; they can be quickly 
converted back to osteoblasts when needed (Robling et al., 2006). In response to anabolic agents 
or mechanical stimuli, bone-lining cells can induce bone formation, without being coupled with 
bone resorption (Jee, 2001; Robling et al., 2006). This formation, known as formation drifts, 
leads to bone modeling and geometric changes in bone shape.  
B.4 Bone Turnover 
Bone is constantly undergoing remodeling. This remodeling is a result of bone turnover, 
or the constant balance between bone formation and resorption. Exercise and weight bearing 
activities can increase bone formation, whereas disuse, estrogen deficiency, and zero gravity can 
increase bone resorption (Riggs et al., 1998; Jee, 2001; Downey and Siegel, 2006; Robling et al., 
2006).  
Bone formation occurs by the laying down of an organic matrix. This organic matrix, 
known as the osteoid, is unmineralized bone mostly composed of type I collagen. The osteoid is 
then mineralized by infiltration of hydroxyapatite. Bone resorption occurs by osteoclast activity 
breaking up the mineral matrix and releasing hydroxyapatite into the bone environment. When 
calcium or phosphates are needed for mineral homeostasis osteoclasts erode the hydroxyapatite 
and release essential ions, such as calcium.  
Bone turnover replaces damaged, pre-existing bone with new bone, and is a coupling 
mechanism between bone formation and 
resorption. This coupling mechanism 
occurs through the basic multicellular 
unit (BMU) (Jilka, 2003) (Figure 3). 
Figure 3.  Basic multicellular unit. Adapted from [Parfitt, 2000]. 
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Osteoclasts lead the BMU and tunnel through bone, eroding mineralized matrix as the cell 
cluster, known as the cutting cone, advances (Figure 3). The closing cone is composed of 
osteoblasts that follow the cutting cone and lay down the osteoid shortly after old bone is 
resorbed. There is a lag time between the resorption and formation parts of the BMU, which is 
referred to as the resorption cavity. A capillary runs through the center of the BMU providing a 
blood supply, which supplies nutrients, oxygen, and cells necessary for bone turnover. 
B.5 Bone Porosities 
There are three types of porosity found in bone: the lacunar-canalicular porosity 
surrounding osteocytes, the vascular porosity, and the collagen-apatite porosity. The collagen-
apatite porosity (< 10 nm radius) is the space between the mineral component of bone and the 
collagen substructure, created when mineral apatite infiltrates and strengthens the initially 
constructed collagen matrix (Cowin, 1999; Wang et al., 2004). The role of the collagen-apatite 
porosity is unclear; bone fluid is considered to be bound in this matrix, and is not believed to 
participate in interstitial fluid flow (Wang et al., 2004).  
The lacunar-canalicular porosity (~100 nm diameter) is the site of interstitial fluid flow 
around osteocytes (Fritton and Weinbaum, 2009). Fluid flow through the canaliculi and around 
the osteocytes regulates cell signaling and solute transport, which are important for overall bone 
health, as well as repair, turnover, and bone formation.  
The vascular porosity is larger than the lacunar-
canalicular porosity, and is approximately 20-40 µm in 
diameter (2050 µm2 cross-sectional area in humans) 
(Stein, 1999; Fritton and Weinbaum, 2009) (Figure 4). 
Within the vascular canals are blood vessels, nerves, 
Figure 4.  Connections between lacunar-canalicular 
porosity and vascular porosity. Adapted from [Fritton 
and Weinbaum, 2009]. 
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and interstitial fluid. Together, the longitudinally and transversely (Volkman’s canals) oriented 
vascular canals make up the vascular porosity (Fritton and Weinbaum, 2009). These canals carry 
nutrients to and waste away from the lacunar-canalicular porosity (Cowin, 1999) (Figure 4). 
Once cellular waste returns to the blood vessels it is transported out of bone through the 
periosteum and into the systemic venous circulation.  
The lacunar-canalicular and vascular porosities are connected to facilitate bone’s 
transport mechanism. Bone acts as a poroelastic material, i.e., a porous solid filled with fluid 
(Piekarski and Munro, 1977; Cowin, 1999). Movement-induced loading exerts mechanical forces 
on bone, causing fluid pressure to increase within the pores. This increase in pressure creates a 
gradient, and causes fluid flow through bone (Cowin, 1995; Knothe Tate, 2003). Shear stress and 
the resulting drag forces from this fluid movement are believed to allow osteocytes to sense 
changes in their environment, and are the important mechanisms for bone signaling (Klein-
Nulend et al., 2003; Wang et al., 2007). The vascular porosity connects with the lacunar-
canalicular porosity, and not only serves as a source for nutrients and cells, but also provides a 
pressure relaxation mechanism to help regulate the interstitial fluid flow (Cowin, 1999).  
B.6 Bone Mechanotransduction 
Bone mechanotransduction is the signaling process that converts mechanical forces to 
biochemical and cellular responses to maintain bone structure (Klein-Nulend et al., 2003; Fritton 
and Weinbaum, 2009). Since osteocytes are present in high numbers in bone, and have an 
interconnected structure with a large surface area, they are thought to be the cells responsible for 
detecting strain and translating strain into signaling (Bonewald, 2006). The osteocyte processes 
are connected to the canalicular wall via tethering elements and integrin attachments (Wang et 
al., 2007) (Figure 5). The most established theory suggests that fluid flow through the 
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pericellular space surrounding the osteocyte dendrite creates a drag force, deforming these 
tethering elements (Wang et al., 2007) (Figure 5). The combination of the tethering elements and 
integrin attachments at the canalicular and cell surfaces results in strain amplification. Since 
realistic tissue-level strains from movement-induced mechanical loading are approximately 0.04-
0.3% (Fritton et al., 2000; You et al., 2004), and too small to cause a signaling cascade, strain 
amplification is a vital process for mechanotransduction (You et al., 2004). Changes in number 
or pattern of the tethering elements due to disease could disrupt fluid flow, altering shear stress 
and drag forces (Knothe Tate, 2003).  
Osteocyte signaling for coordination of bone activity is a vital aspect of 
mechanotransduction. Signaling is thought to occur via integrin receptors on the osteocyte 
membrane, which secrete signaling molecules such as nitric oxide (NO), specifically eNOS 
(endothelial nitric oxide synthase) and prostaglandins (Klein-Nulend et al., 2003). NO is 
expressed by osteocytes, osteoblasts, and endothelial cells, due to shear stress, which is caused 
by mechanical loading and fluid flow (Bonewald, 2006). Nitric oxide inhibits osteoclast 
function, but stimulates osteoblast differentiation and activity (Kasten et al., 1994; Hikiji et al., 
1997; Bonewald, 2006). NO also protects endothelial cells against apoptosis, and may have a 
similar effect on osteocytes (Tan et al., 2008). Additionally, estrogen has been shown to increase 
Figure 5. (Left) EM images of an osteocyte process, demonstrating the tethering elements and canalicular protrusions that 
connected the process to the canalicular wall. (Right) Model of osteocyte process, canaliculus, and associated integrin 
attachments. Adapted from [Wang et al., 2007].  
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nitric oxide production and bioavailability in the endothelium (Duckles and Miller, 2010) and in 
bone (Armour and Ralston, 1998; van’t Hof and Ralston, 2001). NO is an important mediator of 
bone, and changes in expression of nitric oxide could significantly alter the balance between 
formation and resorption.  
Prostaglandins are also important signaling molecules for mechanotransduction. As with 
nitric oxide, prostaglandins, specifically PGE and PGI, inhibit osteoclast activity, but promote 
osteoblast activity (Bergmann et al., 2010). Osteocytes produce prostaglandins in response to 
shear stress. Because prostaglandins prevent osteocyte apoptosis, decreases in prostaglandin 
levels cause cell death, sequentially causing osteoclast bone resorption (Bonewald, 2006).  
B.7 Long Bones  
A typical long bone contains three main regions: the 
epiphysis, metaphysis, and diaphysis (Figure 6). The epiphysis, 
the widest part of long bones, is covered by articular cartilage, 
and bears most of the mechanical loading, which is transmitted 
down to the diaphysis. The metaphysis contains the growth 
plate, or epiphyseal plate, and connects the epiphysis and 
diaphysis. The epiphyseal plate is hyaline cartilage, present in 
growing animals, and the site of longitudinal growth; this plate 
calcifies into cancellous bone during puberty, after which 
longitudinal growth stops. The diaphysis is the longest part of a 
long bone, and contains cortical bone and the medullary cavity 
(Figure 6). The periosteum is the highly vascular lining that encases the outer surface of bone. 
The medullary cavity contains bone marrow, and is surrounded by a thin lining known as the 
Figure 6. Structure of a long bone. 






endosteum. There are two types of bone marrow, red and yellow marrow, which are a part of the 
bone vasculature. Red marrow is responsible for formation of platelets and red and white blood 
cells, and yellow marrow is composed of fat cells. The function of yellow marrow is not well 
understood (Rosen et al., 2009). 
B.8 Blood Supply in a Long Bone 
Bone vasculature is extremely important in maintaining the everyday functions of long 
bones; it is also important during trauma and disease. Bone receives a large portion of the body’s 
total cardiac output, about 17% (Brookes and Revell, 1998), and this high vascularity of bone 
allows for turnover and repair. Bone vasculature is also an important regulator of vasoactive 
factors and hormones in bone, which are crucial for regulation of the skeleton (McCarthy, 2006). 
Since blood flow is necessary for bone formation and function (Parfitt, 2000), bone vasculature 
is important to consider when studying bone.  
The blood supply to human bone is divided into afferent vessels, which lead into the 
microvascular network, and then into the efferent vessels. The afferent vessels are composed of 
nutrient arteries that extend from a nearby systemic artery (Winet, 2001). This systemic artery 
bifurcates, and forms an elaborate blood vessel network surrounding the bone (Brookes and 
Revell, 1998). The nutrient arteries arise from this network, and penetrate the epiphysis, 
metaphysis, and diaphysis of long bones (Laroche, 2002) (Figure 7). Generally, the epiphysis, 
metaphysis, and diaphysis have their own nutrient arteries that distribute blood to each area. 
These large arteries penetrate the bone, and continue through the cortex into the bone marrow 
(Winet, 2001; Laroche, 2002) (Figure 7). The diaphyseal nutrient artery helps to supply the 
growing metaphysis with blood, while the mature metaphysis is solely supplied by the 
metaphyseal nutrient artery (Brooks and Revell, 1998; Pazzaglia et al., 2008).  
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Once inside the medullary canal of long bones 
the nutrient arteries branch, and distribute blood to the 
bone marrow and cortical and cancellous bone. The 
medullary arterioles result from the bifurcating 
nutrient arteries, and are responsible for controlling 
blood flow rate through contraction and relaxation of 
precapillary sphincters and smooth muscle within the 
vessel wall (Laroche, 2002). These arterioles lead into 
a bone marrow sinusoidal network, as well as the 
capillaries found in cortical bone (Laroche, 2002). The 
marrow sinusoids and cortical capillaries connect with 
each other at the interface between cortical bone and the medullary cavity (Brooks and Revell, 
1998).  
The venous circulation in bone is similar to the arterial circulation. Collecting sinuses and 
nutrient veins exist not only in the marrow cavity, but also in the periosteum. Veins in the 
medullary cavity collect venous blood from the bone marrow sinusoids, whereas veins in the 
periosteum and surrounding musculature collect blood from the cortical capillaries (Laroche, 
2002). There are many more veins than nutrient arteries in bone, allowing for proper drainage of 
blood and interstitial fluid (Brookes and Revell, 1998).   
 The microvasculature within the cortex supplies cortical bone, and is mainly composed 
of capillaries. In human long bones, the blood vessels within the vascular pores run 
longitudinally, which results from orientation with the major loading direction, and transversely 
(Volkmann’s Canals) (Winet, 2001). There are one to four vessels within each canal (Winet, 
Figure 7. Arterial blood supply in long bones. 
Adapted from [Laroche, 2002]. 
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2001), but usually one in the mature skeleton (Brooks and Revell, 1998). An artery and vein can 
coexist in the largest canals, but most canals contain capillaries (Laroche, 2002). These 
capillaries do not contain smooth muscle, and are approximately 10-20 µm in diameter 
(Pazzaglia et al., 2008). The endothelial cell lining is approximately 0.1-0.5 µm thick (Winet, 
2001). Angiogenesis (defined as blood vessel formation from pre-existing vessels) can occur at 
different points along the length of the vessel, and the diameter can change as well. Thus, vessel 
morphology and diameter are largely dependent on cross-sectional sampling.  
Blood flow (perfusion) in long bones is centrifugal in young humans and small laboratory 
animals, and flows from the medullary cavity towards the periosteum. In general, blood flows 
from the systemic arterial circulation through the bone marrow and cortical bone, and back to the 
systemic venous circulation (McCarthy, 2006). This centrifugal flow is maintained through a 
pressure gradient between the medullary cavity and the periosteum; the blood vessel medullary 
cavity pressure is approximately 45-60 mmHg in humans (equal to arterial blood pressure) 
(Brooks and Revell, 1998; Cowin, 1999), and the blood vessel periosteal pressure is about 12-15 
mmHg (Brooks and Revell, 1998). With aging, it is suggested that blood flow changes from 
centrifugal to centripetal; cortical blood flow is then supplied from the periosteal side and moves 
toward the medullary cavity (Bridgeman and Brookes, 1996). The reversal of cortical blood flow 
in aging long bones is due to medullary ischemia and reduced marrow pressure (Bridgeman and 
Brookes, 1996). Blood flow rate in humans is normally about 5 mL/min/100g in cortical bone, 
and 20 mL/min/100g in cancellous bone (Laroche, 2002; McCarthy, 2006), which significantly 
decreases with aging (Brookes and Revell, 1998). 
Bone commonly adapts its shape and size to accommodate different physiological 
conditions; the vascular system in bone is no exception. Blood vessels have been shown to 
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change morphology during alterations in lifestyle. Exercise, for example, increases the 
vasculature (capillary density) in bone in the aging rat (Viboolborakul et al., 2009). Increased 
vascularization is also important for fracture repair. Blood clotting and neovascularization are the 
first steps in fracture repair, and angiogenesis always accompanies bone formation. Lu et al. 
(2008) demonstrated that aging decreases vascularization during fracture healing, and slows the 
recovery time in adult male mice. Additionally, Mekraldi et al. (2003) demonstrated that blood 
vessel morphology changes in the diseased state. Blood vessel number and area decreased in the 
secondary spongiosa of the rat tibia after ovariectomy, and VEGF and nitric oxide expression 
was reduced. More research is needed to determine how estrogen reduction affects the bone 
vasculature.   
The relationship between estrogen and the bone vasculature is important to fully 
understand how menopause initiates osteoporosis. While estrogen is known to affect afferent 
vessels, the ways in which estrogen influences capillary-sized vessels in cortical bone is less 
understood. Bone arterioles have estrogen receptors, specifically ER-α and ER-β, and thus have 
the capacity to respond to estrogen (Braidman et al., 2001; Soukhova-O’Hare et al., 2005). 
Endogenous estrogens are thought to act as vasodilators on bone arterioles; therefore, decreases 
in this hormone due to estrogen loss would stimulate vasoconstriction, and decrease the size of 
the blood vessels (Soukhova-O’Hare et al., 2005). Additionally, ER-β receptors have been found 
on osteoblasts and osteocytes, and in osteoclast nuclei and capillaries in bone (Braidman et al., 
2001). This suggests that estrogen could have an effect on capillary-sized vessels as well. Since 
capillaries do not have smooth muscle, it is most plausible that any changes in morphology of 
bone capillaries are dictated by what occurs in the bone arterioles and larger vessels. The effect 
of estrogen on capillaries is, therefore, less about direct vasodilation/vasoconstriction, and is 
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most likely related to changes in shear stress and endothelial dysfunction, characterized by 
reduced nitric oxide availability and increased oxidative stress (Flammer and Lüschera, 2010). In 
the rat OVX model (12-14 weeks old), Soukhova-O’Hare et al. (2005) demonstrated that bone 
medullary arterioles express ER-α, ER-β, and endothelial nitric oxide synthase (eNOS) 
receptors, and that OVX arterioles have a smaller baseline diameter relative to the control; 
however, this study found no difference in eNOS expression or NO-dependent dilator effects on 
bone arterioles. Although no change in eNOS expression was observed, these measurements 
were from the bone marrow blood vessels, and cortical bone capillaries could respond 
differently. Decreases in NO production by endothelial cells in cortical capillaries could decrease 
the overall NO levels in cortical bone, thus stimulating osteoclasts, inhibiting osteoblasts, and 
affecting osteocyte signaling.  
Clearly, connections do exist between the bone vasculature, estrogen levels, and 
osteoporosis in postmenopausal women; more in-depth studies need to be performed to more 
clearly define the relationship between these factors.  
B.9 Bone Vasculature and Blood Vessel Assessment 
 Limited information exists on the bone vasculature, partially due to the difficulty of 
studying vessel morphology and blood flow in bone. Vessel morphology is mainly studied 
through three different modalities: histology, immunohistochemistry, and radiographic 
techniques. Basic histological staining can be performed on paraffin (for decalcified bone) and 
plastic (for calcified or decalcified bone) embedded samples to stain the endothelial cells, blood 
cells, and the vessel lumen. Standard, non-specific morphological stains, such as Hematoxylin 
and Eosin, color the bone matrix and nuclei of cells. Goldner’s Trichrome is another basic 
histological stain that can be used with calcified tissue, which highlights the osteoid (pink), 
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mineralized matrix (green), and cells (brown) (Goldner, 1938). Goldner’s Trichrome has been 
used to stain for blood vessels in plastic-embedded calcified bone (Laroche et al., 1996).  
Immunohistochemistry is used in paraffin-embedded samples for specific staining of 
bone blood vessels and identification of cells. Antibodies such as platelet endothelial cell 
adhesion molecule (PECAM-1/CD31) (Lu et al., 2008) and vascular endothelial growth factor 
(VEGF) (Garcia-Ramirez et al., 2000; Ferrara and Gerber, 2001) are established endothelial cell 
markers, and have been used to identify blood vessels in bone. The aforementioned antibodies 
can only be used on decalcified paraffin-embedded samples; this scenario is not ideal for taking 
measurements because normal bone is mineralized, and any decalcified morphological 
information is not an accurate representation of the in vivo condition.   
Radiographic techniques have been used to assess three-dimensional bone vasculature. 
Micro-computed tomography (micro-CT) has been used in conjunction with vascular perfusion 
techniques. The animal’s vascular system is perfused with a compound such as Barium Sulfate 
(Jia et al., 2010; Sider et al., 2010) or Microfil (Sider et al., 2010), and the compound completely 
fills the bone capillaries. The vascular system can then be visualized with micro-CT imaging by 
separating the blood vessels from the mineralized matrix through thresholding, and 
decalcification improves visualization of the blood vessels. While valid options exist for 
investigation of the vascular porosity and bone vasculature, they are challenging and a 
comprehensive assessment has yet to be performed. 
B.10 Osteoporosis 
Osteoporosis is the leading bone disease in the United States, affecting approximately 10 
million Americans (National Osteoporosis Foundation, 2011). Osteopenia, which is low bone 
mass, is the precursor to osteoporosis. Osteoporosis is characterized by a deterioration of bone 
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mass and altered microarchitecture, which leads to decreased bone quality, increased bone 
fragility, and the risk of fracture. Osteoporosis is caused by an imbalance between the two phases 
of bone turnover: formation and resorption (Turner et al., 2001). This imbalance leads to more 
osteoclast removal of bone than osteoblast formation of new bone, resulting in an overall loss of 
bone mass (Thompson et al., 1995). According to the National Osteoporosis Foundation, women 
are more susceptible to osteoporosis than men, and postmenopausal women have an increased 
risk of developing osteoporosis due to the extreme decline of estrogen production. A loss in bone 
mass can also be caused by prolonged bed-rest, cancer, Paget’s disease, bone inflammatory 
diseases such as rheumatoid arthritis, diabetes, and hormone disorders including thyroid, 
parathyroid, and testosterone issues (Rodan and Martin, 2000; National Osteoporosis 
Foundation, 2011). While these conditions can ultimately lead to bone fragility, estrogen 
deficiency remains the most common cause of osteoporosis among women, and is suggested as a 
primary impetus for changes in bone mass.  
Although osteoporosis more commonly affects women, men can also suffer from this 
disease. The most common causes of osteoporosis in men include secondary 
hyperparathyroidism, low androgen levels, glucocorticoid medication, excessive smoking and 
alcohol use, gastrointestinal disease, and immobilization. Genetic diseases and issues with 
estrogen receptors are also responsible for inducing osteoporosis in men (Riggs et al., 1998).  
In order to help alleviate the effects of postmenopausal osteoporosis, and restore quality 
of life to these patients, the relationship between estrogen and bone integrity needs delineation. 
The exact mechanism of how estrogen loss decreases bone mass remains unclear; however, 
recently it has been suggested that estrogen regulates osteoclast and osteoblast function. It is 
suggested that osteoblast function significantly decreases due to reduced estrogen levels, while 
 
19 
osteoclast function is enhanced (Kameda et al., 1997; Tobias and Compston, 1999); this 
combination quickly alters bone composition.   
Osteocyte viability is also challenged by estrogen-deficient osteoporosis. Osteocyte 
apoptosis and bone resorption after estrogen withdrawal have been spatially and temporally 
linked (Emerton et al., 2009). Cell death was shown to occur directly before bone resorption, and 
to be an important step in signaling osteoclast activity in that same area (Emerton et al., 2009). A 
decrease in the number of osteocytes and disruptions in the associated connectivity would 
significantly alter interstitial fluid flow in this area, thus compromising mechanotransduction and 
bone’s ability to repair damage due to estrogen loss (Emerton et al., 2009).  
B.11 Animal Models of Osteoporosis 
Currently, the ovariectomized (OVX) rat model is the most scientifically accepted animal 
model for studying postmenopausal osteoporosis. This model induces osteopenia in female rats 
by removing the ovaries and significantly reducing the estrogen supply. The proper control is 
sham-operated rats where the animals undergo surgery, but the ovaries remain intact (Kalu, 
1991). This control removes any affects the surgery may have on bone changes. The model is not 
an osteoporosis model, but an osteopenia model because fracture does not occur, as seen in some 
women suffering from postmenopausal osteoporosis. While some studies show that the rat tibia 
continues to grow until approximately 26 weeks of age, with a slower rate in the last several 
weeks, other studies have demonstrated that beyond 20 weeks of age tibial growth has essentially 
stopped, even though the growth plate remains open (Roach et al., 2003; Horton et al., 2008). It 
is important to use a mature rat model so that results are not affected by the continual growth of 
immature animals throughout the study.  
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Ovariectomy in the rat has been shown to significantly affect cancellous bone in the tibia. 
Overall, bone mineral density decreases in the proximal tibia, and this site is the first to exhibit 
bone changes from ovariectomy when compared to the spine (Wronski et al., 1986; Francisco et 
al., 2011) and femur (Francisco et al., 2011); additionally, the proximal tibia is the anatomical 
site that experiences the most severe changes in bone microarchitecture (Francisco et al., 2011).  
There is a significant increase in cancellous bone turnover and bone resorption, and a decrease in 
total cancellous bone in the proximal tibia (Wronski et al., 1986; Kalu, 1991; Thompson et al., 
1995; Brouwers et al., 2009), which has been observed as early as two weeks post-ovariectomy 
(Thompson et al., 1995). Larriera et al. (2010) demonstrated that bone volume fraction and 
trabecular number significantly decrease 
and trabecular spacing significantly 
increases in the OVX rat tibia 
metaphysis (26 weeks old) six weeks 
post-OVX when compared to control 
(Figure 8); additionally, this study found 
no significant changes in trabecular 
thickness and structural model index.  
Other effects of ovariectomy on cancellous bone include changes in osteoclast number 
(Wronski et al., 1986), mineral apposition rate, and bone formation rate, which significantly 
increase fourteen days post-OVX (Thompson et al., 1995).  Similarly, bone volume ratio, bone 
surface ratio, trabecular separation, trabecular number, and connectivity density have been 
shown to decrease in the tibia metaphysis, as assessed with micro-CT imaging (Thompson et al., 
1995; Boyd et al., 2006; Francisco et al., 2011). Decreases in these measurements were observed 
 
Figure 8. Decreased bone volume fraction in 26-week-old Sprague 
Dawley rats sacrificed 6 weeks post-OVX. Adapted from [Larriera et 
al., 2010].  
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two weeks following ovariectomy in some studies (Thompson et al., 1995), and within the first 
month in others (Boyd et al., 2006), except connectivity density, which significantly changed 
two months after estrogen loss (Boyd et al., 2006). At twelve months post-ovariectomy, changes 
in these parameters cease, and bone reaches a new steady state (Thompson et al., 1995). It has 
been reported that individual trabeculae transform from plate-like to more rod-like after 
ovariectomy (Laib et al., 2001; Boyd et al., 2006; Franciso et al., 2011). The effect of OVX on 
trabecular thickness is unclear, with some studies reporting an increase (Waarsing et al., 2004; 
Boyd et al., 2006), some a decrease (Francisco et al., 2011), and some no change (Thompson et 
al., 1995) when compared to sham controls. Increases in trabecular thickness could indicate 
cancellous bone remodeling (Waarsing et al., 2004).  
While cancellous bone is more sensitive to estrogen loss than cortical bone, changes in 
cortical bone do occur. Endocortical remodeling has been shown to take place in the tibia of the 
mature ovariectomized rat, although it did not reach statistical significance compared to sham 
(Wronski et al., 1986). Bone apposition on the endosteal side of cortical bone has been coupled 
with periosteal bone resorption in the OVX rat tibia metaphysis (10 months old) (Waarsing et al., 
2004). Cortical bone mineral density remains unaffected by estrogen loss, but cortical porosity 
and cortical thickness has been suggested to increase and decrease, respectively, which can 
significantly affect bone strength (Sietsema, 1995; Nishiyama et al., 2009; Larierra et al., 2010).  
It has also been suggested that the combination of ovariectomy and aging more significantly 
affects cortical bone (Kalu, 1991). 
Preliminary changes in bone vasculature have also been documented in the 
ovariectomized rat model. The relationship between blood vessel morphology and ovariectomy 
has been studied, albeit superficially. In the secondary spongisosa of the tibia metaphysis, 
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Mekraldi et al. (2003) demonstrated a decrease in blood vessel number in Wistar rats (12-13 
weeks old) sacrificed one and two-weeks post-ovariectomy. Additionally, this group showed that 
blood vessel area decreased in the one week post-ovariectomy group, but the decline in area did 
not reach statistical significance in the two weeks post-ovariectomy group (Mekraldi et al., 
2003). VEGF and nitric oxide mRNA expression also decreased one week post OVX. In this 
study, all changes in the vasculature due to estrogen were prevented by 17β-estradiol 
administration.   
Recently, estrogen-deficient osteoporosis has been linked to decreases in bone perfusion, 
which have also been characterized in the rat OVX model. Induced osteoporosis increases bone 
marrow fat content, and decreases bone mineral density (BMD) and perfusion in the femurs of 
humans and rats (Griffith et al., 2008, 2010). Griffith et al. (2010) also demonstrated that there is, 
in fact, an inverse relationship between BMD and bone perfusion and marrow fat content, which 
is associated with an increase in fat cell number and endothelial dysfunction in the Sprague 
Dawley OVX rat model (6 months old). Similarly, aging and simulated microgravity has been 
linked to a decrease in BMD and perfusion in the rat femur (Prisby et al., 2007; Colleran et al., 
2000). Aging was also connected to a decrease in endothelial dependent vasodilation (Prisby et 
al., 2007).  
Although the rat OVX model has been accepted, the rat skeleton does not undergo bone 
remodeling the same way as human bone. Disadvantages of the rat OVX model include different 
biochemical and cellular pathways than humans, minimal intra-cortical bone remodeling, and a 
small bone size, which limits the amount of samples that can be obtained (Kalu, 1991; Turner et 
al., 2001). While rats do not have Haversian systems, cortical remodeling does occur and is more 
closely correlated with age than disease (Kalu, 1991). Additionally, the Sprague Dawley OVX 
 
23 
model is useful to mimic human osteoporosis because the female rats grow more slowly than the 
male rats and have an overall smaller peak bone mass, as seen in humans (Turner et al., 2001). 
Other osteoporosis models include the mouse, canine, ovine, and primate models. While animals 
cannot exactly model the human situation, they are important tools to better understand diseases, 
and to predict human outcomes of the same disorder. 
B.12 Significance of Project 
Understanding the progression of estrogen-deficient osteoporosis is necessary in order to 
reduce the risk of fracture, sickness, and death among postmenopausal women suffering from 
bone loss and fragility. A vital step to better comprehending this disease is determining changes 
that occur within the microporosity in cortical bone due to estrogen loss. While there fails to be 
an explicit, well-known relationship between the vascular porosity, mechanotransduction, bone 
vasculature, estrogen, and osteoporosis, it is clear that connections do exist. As shown by this 
review of the literature, estrogen loss not only directly influences bone cell activity, but can also 
affect the cortical vascular porosity. This study investigates the previously observed increase in 
the vascular canal diameter in the rat OVX model (Larriera et al., 2010), and potential changes in 
the bone vasculature. The combination of changes in these systems may alter interstitial fluid 
flow and compromise mechanotransduction. Disruptions in fluid flow means altered solute 
transport and shear stresses in the canaliculi, which could potentially lead to insufficient 
stimulation of osteocytes and the disruption of regular bone function. The objective of this study 
is to analyze morphological changes occurring in the vascular porosity and bone vasculature 





C. PROJECT DESCRIPTION 
C.1 Preliminary Studies 
One focus of our lab is to delineate the porosity changes occurring in the rat OVX model 
and correlate these results to postmenopausal osteoporosis. Previous research has focused on the 
lacunar-canalicular porosity surrounding osteocytes; however, this study will center on changes 
occurring in the vascular porosity. Our lab has shown in 2D and 3D confocal microscopy studies 
that the cortical and cancellous lacunar-canalicular porosity increases due to estrogen loss in the 
rat tibia metaphysis six weeks after ovariectomy (Ciani et al., 2009; Sharma et al., 2011). The 
recent 3D study showed that the number and volume of osteocyte lacunae, and the number of 
canaliculi per osteocyte do not change between OVX and Sham groups, but that the canalicular 
volume measured via dye penetration increases in ovariectomized rats by 34% (Sharma et al., 
2011a). Additionally, recent electron microscopy studies from our lab have shown differences in 
canalicular wall appearances and morphology (Sharma et al., 2011b). Combining these results 
with the confocal microscopy studies suggests that the lacunar-canalicular porosity increases are 
due to mineralization or permeability changes in the canalicular walls. Thus, our previous work 
implies that fluid flow throughout the osteocyte network is altered in the OVX condition, which 
can significantly affect osteocyte health and the osteocytes’ ability to orchestrate proper bone 
function (Sharma et al., 2010).  
The literature suggests that bone mechanotransduction theories that only account for the 
lacunar-canalicular porosity are incomplete, and we have begun to delineate the effects of 
estrogen deficiency on the vascular porosity. Most recently we have demonstrated, using high-
resolution micro-CT imaging (1 µm resolution), that the cortical vascular porosity is increased in 
the ovariectomized rat tibia metaphysis (4.10 ± 1.00%) compared to the Sham group (2.80 ± 
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0.38%), and that the average vascular canal diameter is increased from 12.5 ± 3.0 µm in Sham to 
22.0 ± 4.3 µm in OVX.  
While our lab has shown that both the lacunar-canalicular and vascular porosities change 
with estrogen loss, the specific effects of ovariectomy on the vascular porosity in the mature rat 
model needs delineation and is explored in the following sections. Specifically, research 
hypotheses and methods to investigate why the vascular porosity increases and further 
morphological changes within the canals and blood vessels are outlined.  
C.2 Specific Aims: 
The proposed research will test the following global hypothesis:  
We hypothesize that estrogen deficiency, as experienced by postmenopausal women, alters 
the vascular canal and blood vessel morphology in cortical bone.   
 
From this global research hypothesis, the corresponding specific aims are as follows:  
Specific Aim 1: To determine if the increased vascular porosity and average canal diameter 
previously observed in rat cortical bone after ovariectomy (Larierra et al., 2010) occurs 
through osteoclast resorption. We investigated this specific aim using female Sprague Dawley 
rats that underwent ovariectomy at 20 weeks-of-age and were sacrificed 1 and 2 weeks post-
ovariectomy. Osteoclast resorption was assessed through changes in osteoclast numbers and 
activity, which were determined by Tartrate-Resistant Acid Phosphatase (TRAP) enzymatic 
staining. Samples were obtained from the proximal metaphysis and mid-diaphysis of the rat tibia, 
with the region of interest (ROI) being cortical bone.   
Specific Aim 2: To determine if estrogen deficiency alters blood vessel number and 
morphology in the cortical vascular canals. Using the same rat model as in Specific Aim 1, 
Goldner’s Trichrome histological stain was used to determine changes in the number and size of 
blood vessels within the cortical vascular canals in the proximal tibia metaphysis. 
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D. EXPERIMENTAL METHODS 
D.1 Animal Model 
 The ovariectomized rat model of postmenopausal osteoporosis was used to observe 
changes in the vascular porosity due to reduced estrogen levels. Twenty-four female Sprague 
Dawley rats (20 week old, Harlan Laboratories) were divided into two groups. The OVX group 
(n=12) underwent bilateral ovariectomy, and the Sham group (n=12) underwent sham surgery 
where the ovaries were exposed and then returned to the abdominal cavity. The animals were 
allowed to acclimatize after surgery for one week and were fed ad libitum. The OVX group was 
then pair-fed to the average food intake of the Sham group for the rest of the study. Six animals 
from both groups were sacrificed by carbon dioxide inhalation at two different time points post-
surgery, one and two weeks (OVX, n=6 and Sham, n=6 for both time points). The animal body 
weight and uterine horn weight were recorded at sacrifice. The right tibia of each rat was excised 
and cleaned of any soft tissue, and the whole bone length was measured. The tibias were then cut 
approximately 2 mm below the growth plate and at the diaphyseal mid-point, and fixed in 10% 
phosphate-buffered formalin for 48 hours (Figure 9). Permission for this study was granted by 








Figure 9. Dissection of tibia for optimal fixation and 
histological analysis of different regions. Dotted lines indicate 
cutting lines. ROI = Region of interest. 
Tibia metaphysis ROI Tibia mid-diaphysis ROI 






D.2 Vascular Canal Resorption Analysis 
 To determine osteoclast activity within the cortical vascular canals, the tibia metaphysis 
and mid-diaphysis (see tibia metaphysis and mid-diaphysis ROI, Figure 9) were decalcified in 
20% ethylenediaminetetraacetic acid (EDTA) for one week, processed using the Tissue-Tek VIP 
machine (Miles Scientific), and embedded in paraffin wax. After embedding, longitudinal 
sections of the tibia metaphysis and mid-diaphysis were cut (7 µm thick) using the Leica 2030 
Biocut microtome and mounted on Superfrost Plus microscope slides (Cardinal Health). Tartrate-
Resistant Acid Phosphatase (TRAP) enzyme staining was performed to quantify osteoclast 
activity (Appendix K). Briefly, the sections were brought to water using the graded alcohols and 
xylene. They were then soaked in 0.2M Tris-HCl buffer (pH 9.4) for one hour, and in 1M 
Sodium Acetate buffer (pH 5.0) overnight. The slides were stained for the TRAP enzyme, and 
counterstained with 1% Methyl Green.  
 A Nikon Microphot-FXA microscope (Hospital for Special Surgery, NY, NY) and 
Bioquant software (V8.0) (Bioquant Image Analysis Corporation) were used for the analysis 
(Appendix K). For each animal, two measurements were taken for the anterior and posterior 
regions of the tibia metaphysis and mid-diaphysis: 1) total number of vascular canals with TRAP 
activity (20X objective) and 2) if TRAP activity was present, the total number of osteoclasts 
within the vascular canal (40X objective). For each measurement using the 20X objective an area 
of cortical bone equal to the microscope field of view (508 µm x 380 µm) was chosen closest to 
the metaphysis and mid-diaphysis regions of interest (Figure 9). All measurements taken at 40X 
pertained to the canals previously viewed in the 20X ROI. Osteoclasts were identified by the 
presence of concentrated red dye and multiple nuclei (Figure 10). One section per anatomical site 
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(anterior metaphysis, posterior metaphysis, anterior mid-diaphysis, posterior mid-diaphysis) per 









D.3 Vascular Canal and Blood Vessel Morphology Analysis  
 To assess changes in vascular canal and blood vessel number and morphology, the 
proximal tibia (Figure 9) from each animal was embedded in polymethyl methacrylate (PMMA) 
with the protocol adapted from Erben (1997) (Appendix K). After embedding, whole cross-
sections were cut (7 µm thick) from the tibia metaphysis approximately 2 mm below the growth 
plate (see proximal tibia ROI, Figure 9). The sections were stained with Goldner’s Trichrome 
(Goldner, 1938) (Appendix K). Goldner’s Trichrome stains the mineralized matrix (green), the 
osteoid (pink), and cells (brown), and was chosen because the vascular porosity morphology and 
bone turnover were easy to view. Briefly, the sections were deplasticized in xylene-chloroform 
(1:1) and brought to distilled water. The slides were immersed in a series of color stains: 
Weigert’s Hematoxylin, Ponceau-acid fuschin, Phosphomolybdic acid, and Light Green. After 
each stain the slides were rinsed in either water or 0.5% acetic acid. The sections were then 
Figure 10. Example of TRAP activity in the vascular 
canals for quantification of osteoclast resorption in 




dehydrated in ascending grades of alcohol, cleared in xylene, and coverslipped with mounting 
media Cytoseal 60 (Richard Allen Scientific). 
The Nikon Microphot-FXA microscope and Bioquant software were used for the analysis 
(Appendix K). Using the 20X objective, the number of cross-sectional vascular canals and blood 
vessels within each canal were determined in the anterior and posterior regions of the proximal 
tibia metaphysis (2 ROIs per region) and quantified per unit area. Vascular canal and blood 
vessel diameter were measured using the 40X objective (Figure 11). The smallest cross-sectional 
diameter was measured for both canal and vessel, and the endothelial cell lining was excluded 
from the blood vessel dimensions (Figure 11). For both anterior and posterior regions all 









D.4 Statistical Analysis 
 All statistical analyses were performed using Prism 5 (Graphpad Software, Inc.). 
Statistical differences between OVX and Sham for body weight, uterine horn weight, and tibia 
length were determined using unpaired, two-tailed Student’s t-tests. Differences in TRAP 
(osteoclast) activity were determined using a two-way ANOVA with the two factors being 
Figure 11. Measurement of vascular canal and blood vessel 
diameter in PMMA-embedded bone. 
Blood Vessel Diameter 
Vascular Canal Diameter 
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treatment (OVX vs. Sham) and time post-OVX (one week vs. two weeks) for each anatomical 
site (anterior metaphysis, posterior metaphysis, anterior mid-diaphysis, posterior mid-diaphysis). 
Differences in vascular canal density, number of blood vessels per canal, vascular canal 
diameter, and blood vessel diameter were also assessed for each anatomical site (anterior 
metaphysis and posterior metaphysis) using a two-way ANOVA with the two factors being 
treatment (OVX vs. Sham) and time post-OVX (one week vs. two weeks). Bonferroni post-test 




Ovariectomy was confirmed by uterine horn atrophy. The average uterine horn weight for 
OVX rats was significantly less than Sham both one and two weeks post-ovariectomy (Table 1).  
While one week after ovariectomy there was no change in body weight, two weeks after surgery 
the OVX group had increased in weight compared to Sham (9% increase, Table 1). There were 
no differences in tibia length at either time points (Table 2).  
 Osteoclast resorption as assessed through TRAP enzyme activity was minimal, and there 
were no significant differences between groups with respect to anatomical site (metaphysis vs. 
mid-diaphysis), region (anterior vs. posterior), or time post-surgery (one week vs. two weeks) 
(Table 3). There were no differences in the vascular canal density in Sham and OVX groups with 
regard to anatomical site or time post-surgery. Additionally, the average number of blood vessels 
per canal was approximately 1.0 for both groups and time points in the anterior and posterior 
regions (Table 4). There were also no differences in average vascular canal diameter or average 
blood vessel diameter with regard to anatomical site or time post-surgery in Sham or OVX 
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groups (Table 5); however, the average vascular canal diameter and average blood vessel 
diameter in the posterior metaphysis were significantly smaller compared to the anterior 
metaphysis for both Sham and OVX animals at one and two weeks post-surgery (Table 5).  
  
 
Table 1. Uterine horn and body weights for Sham and OVX groups 1 and 2 week(s) post-
surgery. 
 Uterine Horn Weight (grams) Body Weight (grams) 
 Time Post-Surgery Sham OVX Sham OVX 
1 Week 0.53 ± 0.10 0.26 ± 0.03* 225.8 ± 4.8 232.8 ± 8.7 
2 Weeks 0.59 ± 0.06 0.17 ± 0.03* 239.5 ± 8.3 261.0 ± 6.6* 
*p < 0.05 compared to Sham  
 
 
Table 2. Right tibia length for Sham and OVX groups 1 and 2 week(s) post-surgery. 
 Right Tibia Length (cm) 
 Time Post-Surgery Sham OVX 
1 Week 3.98 ± 0.04 3.98 ± 0.03 




Table 3. Average number of vascular canals with TRAP activity and average number of 
osteoclasts per active canal in Sham and OVX groups 1 and 2 week(s) post-surgery.  
  Average Number of Vascular Canals with TRAP Activity 
Average Number of 
Osteoclasts per Active Canal 
Anatomical Site Time Post-Surgery Sham OVX Sham OVX 
1 Week 0.0 ± 0.0 0.0 ± 0.0 0.0 0.0  Anterior 
Metaphysis 2 Weeks 0.2 ± 0.4 0.2 ± 0.4 1.0  1.0  
1 Week 0.0 ± 0.0 0.2 ± 0.4 0.0  4.0  Anterior  
Mid-diaphysis 2 Weeks 0.0 ± 0.0 0.0 ± 0.0 0.0  0.0  
1 Week 0.2 ± 0.4 0.0 ± 0.0 4.0  0.0  Posterior 
Metaphysis 2 Weeks 0.0 ± 0.0 0.0 ± 0.0 0.0  0.0 
1 Week 0.0 ± 0.0 0.2 ± 0.4 0.0  1.0 Posterior  





Table 4. Average vascular canal density and number of blood vessels per canal for Sham and 
OVX groups 1 and 2 week(s) post-surgery.  
 
 
Average Vascular Canal 
Density (# canals/mm2) 
Average Number of Blood 




Surgery Sham OVX Sham OVX 
1 Week 51.8 ± 18.7 52.5 ± 17.9 1.1  ± 0.4 1.1 ± 0.4 Anterior 
Metaphysis 2 Weeks 48.4 ± 15.5 45.6 ± 14.9 1.0 ± 0.2 1.0 ± 0.2 
1 Week 52.1 ± 26.6 50.2 ± 21.0 1.0 ± 0.2 1.1 ± 0.3 Posterior 




Table 5. Average vascular canal diameter and blood vessel diameter for Sham and OVX groups 
1 and 2 week(s) post-surgery.  
 
 
Average Vascular Canal 
Diameter (µm) 





Surgery Sham OVX Sham OVX 
1 Week 16.3 ± 6.2 15.2 ± 5.3 10.9 ± 3.9 9.9 ± 3.9 Anterior 
Metaphysis 2 Weeks 14.1 ± 5.1 13.5 ± 4.6 10.2 ± 3.4 10.5 ± 3.9 
1 Week 12.7 ± 4.7+ 13.5 ± 5.5+ 8.4 ± 3.0+ 8.3 ± 2.9+ Posterior 
Metaphysis 2 Weeks 11.9 ± 4.0+ 12.5 ± 4.4+ 8.4 ± 2.5+ 9.8 ± 3.3+ 
+p < 0.05 compared to anterior site of same time point and treatment 
 
F. DISCUSSION 
 The objectives of this study were two-fold: to determine if osteoclast resorption is the 
primary mechanism behind the increased cortical vascular porosity and canal diameter 
previously observed with micro-CT imaging in the rat OVX model (Larriera et al., 2010), and to 
determine the effects of estrogen loss on blood vessel morphology in cortical bone. Both 
objectives were assessed one and two weeks after ovariectomy of 20-week-old female Sprague 
Dawley rats.  
 Previous studies determined that the vascular porosity in the cortical tibia metaphysis of 
rat bone increases by 32% as assessed 6 weeks after ovariectomy (Larriera et al., 2010). Larriera 
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et al. (2010) also reported an increase in vascular canal diameter in this same region in OVX rats. 
The present study shows no statistical differences in osteoclast activity in the OVX group 
compared to Sham with regard to location, anatomical region, or time. The low level of 
osteoclast activity suggests one and two weeks may not be enough time for osteoclast 
recruitment and resorption. Studies to quantify changes in osteoclast activity 6 weeks post-OVX 
are underway, and this information will provide more concrete conclusions as to if osteoclast 
resorption causes the vascular canal changes after estrogen loss reported in Larriera et al. (2010); 
however, if insignificant levels of TRAP activity are observed 6 weeks post-OVX, it can be 
concluded that osteoclast resorption is not the primary mechanism by which the cortical vascular 
porosity increases. In this case other mechanisms need to be considered.  
 Mineral degradation and bone resorption occur through a pH change in the bone 
microenvironment. Osteoclasts, for example, secret hydrogen ions, among other compounds, 
which cause an acidic pH change (pH~3.5) and erode bone (Jee, 2001); however, other 
mechanisms could potentially create an acidic milieu and initiate bone resorption. Matrix 
metalloproteinases (MMPs) are enzymes that can degrade bone through proteolysis (Page-
McCaw et al., 2007), and may be important candidates to describe the increased vascular 
porosity and canal diameter. Specifically, MMP-2 and 14 are known to cleave type I collagen, 
and could contribute to resorption (Page-McCaw et al., 2007). Other mechanisms through which 
changes in bone pH could occur include alterations in blood pH or oxygen tension (Arnett, 
2010). Griffith et al. (2010) demonstrated decreased perfusion in the rat OVX vertebrae, and this 
reduced blood flow could induce hypoxia (low oxygen) in the vascular porosity. Since the bone 
vasculature is a part of the vascular porosity, blood acidosis and hypoxia could decrease the pH 
inside the vascular canals and increase mineral metabolism.  
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 For the vascular canal density there were no statistical differences between OVX and 
Sham at either time points as assessed through histology. Two weeks is a relatively short time for 
bone turnover and alterations in canal density in skeletally mature rats, and it is possible that 
changes will be significant 6 weeks post-OVX. Although not statistically different between 
Sham and OVX in this study, vascular canal diameter was found to be similar to the Sham values 
reported in Larriera et al. (2010). Vascular canal diameter will be quantified in the 6 weeks post-
OVX time point as well, and is expected to increase in the ovariectomized rats as seen in the 
previous micro-CT studies. Throughout the one and two weeks post-surgery animals a circular 
osteoid (unmineralized bone) was intermittently present around the circumference of the vascular 
canals in equal amounts in Sham and OVX animals (Figure 12). This osteoid thickness will be 
quantified in the 6 weeks post-surgery animals to determine any differences between OVX and 
Sham groups. No differences in the cortical vascular canal diameter seen in the 6 week time 
point animals would contradict the micro-CT data. A potential explanation could be attributed to 
micro-CT thresholding, which would have separated the unmineralized osteoid from mineralized 
bone and would not have incorporated the osteoid into the canal diameter measurements, thus 








Figure 12. An example of the osteiod (pink) that occasionally surrounds vascular canals in Sham and OVX animals at one and 
two weeks post-surgery. Images stained with Goldner’s Trichrome and taken with light microscopy (60X oil immersion lens). 
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 Blood vessel diameter remained relatively constant in OVX and Sham groups one and 
two weeks after ovariectomy. The average blood vessel diameter was approximately 10.2 µm in 
the anterior metaphysis, whereas the posterior metaphysis average blood vessel diameter was 
approximately 8.7 µm. While two or three blood vessels were occasionally present in a single 
canal, the average blood vessel per canal was approximately 1.0 for both groups and time points. 
These results suggest that ovariectomy does not affect blood vessel diameter or number as 
observed in other studies that focused on metaphyseal cancellous bone (Mekraldi et al., 2003). It 
is well-established that cortical bone is less susceptible to changes following estrogen loss when 
compared to cancellous bone, and our findings show that the bone vasculature within cortical 
bone is not as affected as in other areas at identical time points (Mekraldi et al., 2003; Soukhova-
O’Hare et al., 2005). To continue this work, blood vessel diameter and number will be assessed 6 
weeks after ovariectomy to determine if changes occur at a later time. If no differences are 
established between OVX and Sham groups at 6 weeks post-surgery it would be plausible to 
conclude that the cortical bone vasculature morphology remains unchanged after estrogen loss, 
most likely because capillaries have no smooth muscle or auto-regulation. Other changes in the 
vasculature could be occurring, which could contribute to alterations in cortical bone 
microarchitecture. Decreases in systemic perfusion or decreases in local perfusion due to 
blockages would prevent cells, nutrients, and oxygen from reaching cortical bone. This would 
significantly impact bone health.  
 
G. CONCLUSIONS 
This study investigated the effects of estrogen loss on morphological changes in the 
vascular porosity and bone vasculature in rat cortical bone. No significant differences were found 
 
36 
in vascular canal and blood vessel size or density, or in the amount of osteoclast activity within 
the porosity. The results to date indicate that any increases in the vascular porosity as assessed by 
micro-CT imaging are not due to osteoclast activity. Additionally, the results suggest that the 
cortical bone vasculature is unaffected by estrogen loss; however, only one- and two-week post-
ovariectomy times were investigated. These time points were much earlier than previous 
publications that found changes in the vascular porosity. The data is incomplete without looking 
at animals six weeks post-ovariectomy (data in progress), and a more complete story will be 
available after completion of this last time point. Although preliminary, this work has begun to 
incorporate the vascular porosity and bone vasculature into the global picture of postmenopausal 
osteoporosis, which will hopefully increase knowledge about this disease.  
  
H. SUMMARY OF FUTURE WORK 
All measurements and observations described above will be investigated 6 weeks after 
ovariectomy and sham surgeries of 20-week-old female Sprague Dawley Rats (OVX, n=6 and 
Sham, n=6). As before, the proximal tibia will be embedded in PMMA for vascular canal and 
blood vessel measurements, and the metaphysis and mid-diaphysis will be decalcified in EDTA 
and embedded in paraffin bone for assessment of TRAP activity (Figure 9). The following will 
be quantified: 
Paraffin-Embedded Bone: 
All measurements will be taken in the anterior and posterior regions of the tibia metaphysis and 
mid-diaphysis. 
 
1. Number of longitudinal vascular canals with TRAP activity in a 508 µm x 380 µm 
area of interest 







All measurements will be taken in the anterior and posterior regions of the tibia metaphysis. 
 
1. Average vascular canal density 
2. Average number of blood vessels per vascular canal 
3. Average vascular canal diameter 
4. Average blood vessel diameter 
5. Percent of vascular canals surrounded by osteiod 
6. Average thickness of osteoid surrounding the vascular canal (if present) 
 
Additionally, in a separate study the bone vasculature will be further analyzed in the rat OVX 
model using the Microfil technique and micro-CT imaging previously described (Section B.9). 
Measurements reported in this study will be confirmed using Microfil, and a 3D representation 
of the vascular porosity and bone vasculature will be constructed for further analysis.  
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K. APPENDIX K – LABORATORY PROTOCOLS  
K.1 PMMA Embedding Protocol 
 
1. Dehydration: 
- 70%   EtOH (2 days) 
- 95%   EtOH (2 days) 
- 100% EtOH (1 day) 
- Isopropyl Alcohol (3 days – change once) 
- Xylene (3 days – change once) 
 
2. Infiltration: 
- Solution 1: 60 mL methylmethacrylate (MMA), 25 mL Butylmethacrylate, 5 mL 
metylbenzoate, 1.2 mL polyethylene glycol (3 days) 
- Solution 2: 100 mL MMA, 0.4 g benzoyl peroxide (3days) 
- Solution 3: 100 mL MMA, 0.8 g benzoyl peroxide (3 days) 
 
Stir each solution for 5 minutes  
 
3. Polymerization: 
- Prepare a solid methacrylate base in the embedding vial, polymerize this before 
  embedding sample 
- Solution: 400 µL N,N-dimethyl-p-toluidine added to 100 mL cold (4ºC) MMA and  
0.8 g benzoyl peroxide 
 
Stir the solution well and keep on ice 
Add the sample and solution to the embedding vial, seal, and polymerize in the freezer for 3 days  
 
 
K.2 Goldner’s Trichrome Protocol 
 
1. Deplasticize in Xylene-Chloroform (1:1) for 45 minutes 
2. 100% EtOH for 10 minutes (2 times) 
3. 95% EtOH for 5 minutes 
4. 70% EtOH for 5 minutes 
5. Distilled water for 5 minutes 
6. Weigerts Hematoxylin for 10 minutes 
7. Rinse gently in tap water 
8. Put the slides in the Ponceau-acid fuchsin staining solution for 12 minutes 
9. Rinse in 0.5% Acetic Acid (2 washes) 
10. Put slides in the Phosphomolybdic Acid for 9 minutes 
11. Rinse in 0.5% Acetic Acid 
12. Put slides in the Light Green for 3 minutes 
13. Rinse in 0.5% Acetic Acid (2 washes) 
14. Dehydrate through ascending grades of alcohols (70%, 95%, 100% - 5 minutes each) 
15. Xylene for 5 minutes (3 times) 
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16. Coverslip immediately using Cytoseal 60 mounting medium (Richard Allen Scientific) 
 
 
K.3 TRAP Enzyme Staining Protocol 
 
1. Bring slides to distilled water using Xylene (3 times - 5 minutes each) and graded alcohols 
(100%, 95%, 70% - 5 minutes each) 
2. 1 hour in 0.2M Tris-HCl buffer (pH 9.4) 
3. Overnight in 1M Na Acetate buffer (pH 5.0)  
4. TRAP staining as follows: 
- Solution A: Dissolve 50 mg Sodium Nitrite in 1.25 mL distilled water. 
- Solution B: Take 100 µl of solution A and add 100 µl hexosatised pararosanilin: new 
fuchsin, add 35 mL of 1M Na Acetate buffer (pH 5.0) and 35 mg tartaric acid, and 
mix well 
- Solution C: Dissolve 40 mg of Napthol ASBI phosphate in 2 mL Dimethylformamide 
- Add all of Solution B to Solution C 
- Filter stain solution and place slides in 37ºC for 20 minutes 
5. Counterstain with 1% Methyl Green for 1 minute and rinse in distilled water 
6. Do not coverslip with solvent based mounting media - TRAP color will fade 
 
Recipe for 0.2M Tris-HCl (1 Liter): 
- 31.52g Trizma Hydrochloride in 700 mL distilled H2O 
- pH to 9.4 
- Add enough water to make 1 Litre. 
- *Note: MW =157.6 for Trizma 
 
Recipe for Sodium Acetate Buffer (500 mL): 
- 8.2 g Sodium Acetate in 400mL distilled H2O 
- pH to 5.0  
- Add enough water to make 500mL 
 
Recipe for Hexosatised Pararosanilin: New Fuchsin  
- 1g basic fuchsin in 20 mL distilled H2O with 5 mL concentrated HCl 
- Warm gently while mixing  
- Store in the dark at 4ºC 
- This should produce minute bubbles and discolor 1 min 
 
 
K.4 Vascular Canal Resorption Analysis Protocol  
 
Objectives: 
1. To determine the number of vascular canals within the anterior and posterior regions of the 
tibia metaphysis and mid-diaphysis in cortical bone 
2. To determine the percentage of these vascular pores that have osteoclast (TRAP) activity  





- 1 longitudinal paraffin-embedded section per animal sectioned at 7 µm 
- Measurements taken in the anterior and posterior regions for each section 




1. Open Bioquant V8.00 
2. Through the eye-piece, view the longitudinal section in the 1X objective 
3. Identify the anterior and posterior regions nearest the proximal end of the section 
o Metaphysis sections – anterior site located on the outside portion of each mirror 
image of the longitudinally cut bone 
















4. Focus on the top anterior region for the ROI 






















Quantifying Osteoclast activity 
1. Select live image and focus image on the computer screen. Then capture image by clicking 
live image again 
2. Select the following arrays from the “Select Arrays” menu: 
o D14 (for counting the number of vascular canals with TRAP activity) 
o D15 (for counting the number of osteoclasts if TRAP activity is present) 
3. Count the number of vascular pores with TRAP activity at the 20X objective 
o Select D14 from the “Select Arrays” menu 
o From the “Measure” drop-down menu  Manual Measure  
o Click live measure then click measure 
o Click on the vascular canals with TRAP staining (osteoclast activity = red staining)  
o Switch to the 40X objective 
o Select D15 from the “Select Arrays” menu then click measure 














4. File  Copy all data 
5. Open Excel 
6. Paste all data and organize 
7. Repeat protocol for posterior region for metaphysis and diaphysis of each animal 
 
 
K.5 Vascular Canal and Blood Vessel Morphology Analysis Protocol 
 
Objectives: 
1. To determine the number of cortical vascular canals and the number of blood vessels within 
each canal in the anterior and posterior regions of the tibia metaphysis 
2. To measure the diameter of the vascular canals 
3. To measure the diameter of the blood vessels 
4. To quantify all measurements per unit area 
 
Analysis Plan: 
- 3 PMMA-embedded cross-sections per animal sectioned at 7 µm 
- Measurements taken in the anterior and posterior regions for each cross-section 
- 2 ROIs per anatomical region  
Vascular pore with 
osteoclast activity 







1. Open Bioquant V8.00 













3. Focus on the anterior region  
(The anterior region is always the curved point opposite the shortest side) 
 
 
4. Focus the viewfinder on the 1st anterior ROI, and then switch to 10X and then to 20X 
Counting and 





1. Select live image and focus image on the computer screen at 20X. Then capture image by 
clicking live image again 
2. Select the following arrays from the “Select Arrays” menu: 
- A1 (for total tissue area measurement) 
- D14 (for counting the vascular canals) 
- D15 (for counting the blood vessels per canal) 
- I7 (for measuring vascular canal diameter) 
- I8 (for measuring blood vessel diameter) 
3. Define the ROI by tracing the outline of the cortical bone that appears in the captured image  
- From the “Tools” drop-down menu ROI Tools  IROI Cursor  Radius = 1 
- Trace all cortical bone with the cursor 
- Measure approximate size of ROI with scale bar 
4. Create a threshold and measure total tissue area 
- Select Mag = 20X from the “Parameters” menu 
- Click on Select in the “Threshold” menu 
- Click on the ROI until the entire area is red 
- From the “Measure” drop-down menu  Automatic Measure  
o Make sure additive measure is checked 
- Select A1 from the “Select Arrays” menu 
- Auto Measure  preview  measure  total tissue area measurement will appear in 
the data box (µm2) 
- Click on Select in the “Threshold” menu to un-do the threshold 
5. Count the vascular pores and blood vessels at 20X objective 
- Make sure additive measure is unchecked 
- Select D14 from the “Select Arrays” menu 
- From the “Measure” drop-down menu  Manual Measure  
- Click live measure then click measure 
- Click on a vascular canal then right click to take measurement 
 
- Select D15 from the “Select Arrays” menu then click measure 
- Click on each blood vessel within that specific canal then right click  
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- Repeat for all other canals within the 20X ROI 
 
6. Measure the diameter of the vascular pores and blood vessels 
- Return to live image by clicking live image 
- Switch to the 40X objective  
- Select Mag = 40X from the “Parameters” menu 
- Select I7 from the “Select Arrays” menu 
- Click live measure from the “Manual Measure” menu then click measure  
- For each vascular canal previously counted at 20X, click on each side of the object’s 
smallest diameter then right click to perform measurement 
- Select I8 from the “Select Arrays” menu 
- Click measure 
- For each blood vessel click on each side of the object’s smallest diameter then right 
click to perform the measurement 
o Do not take into account the endothelial cell lining 
- Move on to all additional blood vessels 
7. File  Copy all data 
8. Open Excel 
9. Paste all data and organize for first anterior ROI 
10. Repeat protocol steps for the 2nd anterior ROI and copy data to excel sheet 
11. Repeat protocol for 1st and 2nd posterior ROI and copy data to excel sheet 
12. Repeat protocol for 2nd and 3rd slides for each animal 
